Hunan Jiudian Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300705.SZ

Hunan Jiudian Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2023: USD 0.79

Hunan Jiudian Pharmaceutical Co., Ltd. Revenue Per Share is USD 0.79 for the year ending December 31, 2023, a -67.97% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Hunan Jiudian Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 2.46, a 215.19% change year over year.
Hunan Jiudian Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 0.78, a 70.94% change year over year.
Hunan Jiudian Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 0.46, a 12.93% change year over year.
Hunan Jiudian Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2019 was USD 0.40, a 12.68% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

Shenzhen Stock Exchange: 300705.SZ

Hunan Jiudian Pharmaceutical Co., Ltd.

CEO	Mr. Yang Yang
IPO Date	Oct. 10, 2017
Location	China
Headquarters	Building A1, Shibuya Science and Technology Industrial Park
Employees	1,893
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Hunan Jiudian Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company offers antiallergic, anti-infective, and anti-inflammatory drugs; analgosies and gynecological medication products; digestive system products; chemical and Chinese patent medicines; medical instruments; APIs; and other products. It also provides outsourcing services for tablets, capsules, granules, oral solutions, syrups, etc. Hunan Jiudian Pharmaceutical Co., Ltd. is based in Changsha, China.

Key trends

Past 5 years